BioMed Realty Trust, Inc. and Ipsen recently signed a long-term new lease for 62,600 s/f of laboratory and office space at 650 East Kendall St., a six-story, multi-tenant research facility in Kendall Sq. biotechnology super-cluster, which BioMed Realty owns through a joint venture with Prudential Real Estate Investors on behalf of institutional investors. Richards Barry Joyce & Partners represented BioMed in the transaction, with Cresa Boston representing Ipsen.
Commenting on the new, long-term lease with Ipsen, Alan Gold, BioMed's chairman and CEO said, "We are very excited that Ipsen has chosen 650 East Kendall as its Cambridge home for discovery and development of its programs. Ipsen's product offerings, pipeline and global partnership activity serve as a model of scientific innovation and achievement. We look forward to delivering the state-of-the-art facilities that will meet their requirements for years to come."
The 650 East Kendall property is a 282,200 s/f life science research facility that is supported by six levels of below-grade parking. The building received Gold status certification by the Leadership in Energy and Environmental Design (LEED) of the U.S. Green Building Council.
"We are very excited about expanding our research and development efforts to Cambridge, a leading hub in biotechnology research," said Cynthia Sylvestre, president, Biomeasure and vice president and Milford Site Head, Ipsen. "This move puts our research capabilities in the center of Kendall Sq., one of the preeminent life science communities in the world, including prominent hospital centers, medical schools, biotech companies and universities. We are also excited about partnering with BioMed Realty with their specialized expertise in life science real estate."